April 22, 2012
CSOFT featured in Galaxy Newsletter, shares his experience as a panel member at the GALA-sponsored JTF show
March 10, 2012 – CSOFT is featured in Galaxy Newsletter. “Thanks to the Globalization and Localization Association (GALA), I recently had the unique opportunity to speak at Tokyo’s Japan Translation Federation’s (JTF) annual conference. Founded in 1981, the JTF is the largest association of translators and language companies in Japan. It’s quite well organized and boasts a healthy cluster of small, medium and large companies servicing Japan’s language needs. I’m told more than 700 people attended the conference, making this one of the largest language shows in the world.” – Matt Arney, CSOFT VP.
Click here to read the full feature in the Galaxy Newsletter
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com
